Conclusion: SCH during pregnancy is associated with multiple adverse maternal and neonatal outcomes. The value of levothyroxine therapy in preventing these adverse outcomes remains uncertain.
PubMed 26837268 ↗Levothyroxine
Also known as Synthroid, T4
The short answer. There isn't much data on Levothyroxine yet — 27 mentions, 13 with a clear outcome — so treat these numbers as anecdotal. It is most often used for energy: 60% of 10 reports say that improved. It is well studied — 166 meta-analyses on PubMed.
From 27 mentions in total — the rest didn't say how it went and aren't counted.
What Levothyroxine does, according to users
Of the people who reported each effect, the share who said it got better.
7 more with fewer than 3 reports
What the research says
Systematic reviews and meta-analyses from PubMed, with their published conclusions.
3+ meta-analyses or systematic reviews and 10+ randomized controlled trials in humans. The grade measures how much human research exists — read the conclusions below for what it found. 166 meta-analyses on PubMed ↗ · 296 randomized trials ↗
Conclusion: However, further well-designed studies are needed for pre-conceptional treatment, especially in TSH >4.0 mU/L. LT4 treatment during pregnancy had a positive effect on preterm birth; nevertheless, this was only applicable to subclinical hypothyroidism with TSH >4.0 mU/L.
PubMed 38368537 ↗Conclusion: Compared with euthyroidism, subclinical hypothyroidism during pregnancy was associated with a higher risk of pre-eclampsia. There was a U-shaped association of TSH with pre-eclampsia. These results quantify the risks of gestational hypertension or pre-eclampsia in women with thyroid function test abnormalities, adding to the total body of evidence on the risk of adverse maternal and fetal outcomes of thyroid dysfunction during pregnancy. These findings have potential implications for defining the optimal treatment target in women treated with levothyroxine during pregnancy, which needs to be a
PubMed 35255260 ↗Conclusion: There was a J-shaped association of FT4 with cardiovascular disease and mortality. Low concentrations of TSH were associated with a higher risk of all-cause mortality and cardiovascular disease mortality. The 20-40th percentiles of FT4 and the 60-80th percentiles of TSH could represent the optimal healthy ranges of thyroid function based on the risk of cardiovascular disease and mortality, with more than 5% increase of 10-year composite risk identified for FT4 greater than the 85th percentile in women and men older than 70 years. We propose a feasible approach to establish the optimal healthy
PubMed 37696273 ↗337 human trials on ClinicalTrials.gov test Levothyroxine — 197 completed, 30 recruiting now. See all on ClinicalTrials.gov ↗
- Thyroid Hormone Responses to Repeated Wingate Exercise Versus a Non-Exercising Comparison Group · Exercise, Thyroid Function · 2023
- rhTSH for Radioactive Iodine Remnant Ablation in Participants With Differentiated Thyroid Cancer (DTC) · Differentiated Thyroid Cancer · 2026
- Quantitative Pharmacology-Based Dose Adjustment Protocol in Postoperative Thyroid Cancer Patients · Thyroid Cancer · 2026
What government agencies say
Official records from US, Canadian and EU regulators, each linked to its source.
Boxed warning (the FDA's strongest label warning): “NOT FOR TREATMENT OF OBESITY OR FOR WEIGHT LOSS Thyroid hormones, including levothyroxine sodium, either alone or with other therapeutic agents, should not be used for the treatment of obesity or for weight loss. In euthyroid patients, doses within the range of daily hormonal requirements are…”
137 recalls of products named for Levothyroxine. Most recent:
- 2026-09-02 · Class II: Subpotent Drug record ↗
- 2026-07-29 · Class II: Subpotent Drug record ↗
- 2026-07-08 · Class II: Subpotent Drug record ↗
Class I = could cause serious harm; Class II = temporary or reversible harm; Class III = unlikely to cause harm. Recalls are of specific products and lots, not of the ingredient itself. All recalls (openFDA) ↗
300,456 adverse-event reports mention Levothyroxine. Most often reported:
- Fatigue · 25,385
- Nausea · 21,757
- Drug ineffective · 20,682
- Headache · 18,592
- Diarrhoea · 18,033
- Dyspnoea · 16,134
Reports often involve several drugs and serious illness; a report doesn't prove the drug caused the problem, and these counts can't tell you how often it happens. Source query (openFDA) ↗
NIH has funded 18 research projects with Levothyroxine in the title, $3,709,873 in total (1988–2026). NIH RePORTER ↗
Plain-language guides from the US government: MedlinePlus: Levothyroxine ↗
Dosage people report
Reported side effects
How often each side effect came up across all reports.
What users say
First-hand experiences, quoted verbatim. We show one positive and one negative where both exist.
“I was switched to the typical synthetic levothyroxine and havent had the symptoms again.”
“I noticed that my levothyroxine is not working as well anymore and my tsh is high.”
“I was diagnosed as hypo and put on levothyroxin. I spent a couple of years on it and it did put my thyroid function back to 'normal' but I never felt any different really.”
“after 5 weeks of that treatment..i am not feeling that well...still having fatigue,heavy head,lack of motivation AND MOST major problem is Bad sleep”
Top discussions (5)
Levothyroxine compared
Other options for energy
Sources
- User reports: 27 mentions in public discussions, quoted with a link to each discussion (e.g. this thread ↗).
- PubMed (US National Library of Medicine, NIH): meta-analyses ↗ · randomized trials ↗
- ClinicalTrials.gov (NIH): registered trials ↗
- FDA drug label (DailyMed) ↗
- FDA adverse-event reports (FAERS) ↗
- FDA recalls ↗
- MedlinePlus (NIH) ↗
- NIH RePORTER ↗
User data from public discussions; research from PubMed. Information only, not medical advice — talk to a doctor before starting, stopping or combining anything. Data updated October 5, 2026. How we rate